Acorda Therapeutics (ACOR)

32.76 +0.36  +1.11%  May 22, 10:13AM
Add to Watchlists Create an Alert

Acorda Therapeutics Cash from Operations TTM:

52.12M for Dec. 31, 2012
View Full Chart

Acorda Therapeutics Cash from Operations TTM Chart

    Acorda Therapeutics Historical Cash from Operations TTM Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 1   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    Dec. 31, 2012 52.12M
    Sept. 30, 2012 68.35M
    June 30, 2012 91.09M
    March 31, 2012 81.47M
    Dec. 31, 2011 66.34M
    Sept. 30, 2011 34.95M
    June 30, 2011 21.44M
    March 31, 2011 -7.31M
    Dec. 31, 2010 -19.22M
    Sept. 30, 2010 -33.72M
    June 30, 2010 19.32M
    March 31, 2010 34.13M
    Dec. 31, 2009 38.63M
       
    Sept. 30, 2009 34.55M
    June 30, 2009 -61.82M
    March 31, 2009 -59.03M
    Dec. 31, 2008 -49.16M
    Sept. 30, 2008 -42.06M
    June 30, 2008 -32.88M
    March 31, 2008 Go Pro
    Dec. 31, 2007 Go Pro
    Sept. 30, 2007 Go Pro
    June 30, 2007 Go Pro
    March 31, 2007 Go Pro
    Dec. 31, 2006 Go Pro

    About Cash From Operations (TTM)

    Definition: Cash from Operations

    Learn More

    Get data for

    ACOR Cash from Operations TTM Benchmarks

    Companies
    Discovery Laboratories -37.57M
    Biogen Idec 1.864B
    Osiris Therapeutics -13.83M

    ACOR Cash from Operations TTM Rankings

    Overall 72nd percentile
    2180 of 8005
    Sector 78th percentile
    148 of 686 in Healthcare
    Industry 91st percentile
    20 of 248 in Biotechnology

    ACOR Cash from Operations TTM Range, Past 5 Years

    Minimum -61.82M Jun 2009
    Maximum 91.09M Jun 2012
    Average 12.48M